BrainsWay Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRSYF research report →
About the company
BrainsWay Ltd. is a global medical technology company focused on innovating and providing non-invasive neurostimulation therapies for a broad spectrum of mental health and neurological conditions. Operating across the United States, Europe, Israel, and other international markets, the company's core offering is its Deep Transcranial Magnetic Stimulation (dTMS) platform.
- CEO
- Hadar Levy
- IPO
- 2011
- Employees
- 120
- HQ
- Jerusalem, IL
Price Chart
- Market Cap
- $675.78M
- P/E
- 68.73
- P/S
- 10.53
- P/B
- 7.99
- EV/EBITDA
- 80.22
- Div Yield
- 0.00%
- Gross Margin
- 75.50%
- Op Margin
- 10.09%
- Net Margin
- 14.57%
- ROE
- 12.28%
- ROIC
- 6.43%
- Revenue
- $56.53M · 37.83%
- Net Income
- $8.26M · 182.87%
- EPS
- $0.22 · 155.81%
- Op Income
- $4.68M
- FCF YoY
- 170.83%
- 52W High
- $16.84
- 52W Low
- $5.49
- 50D MA
- $16.18
- 200D MA
- $11.08
- Beta
- 0.15
- Avg Volume
- 12
Get TickerSpark's AI analysis on BRSYF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BRSYF coverage
Recent articles, reports, and earnings notes.
No research on BRSYF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BRSYF report →Similar companies
Peers in the same neighborhood.